Cleared Traditional

K962792 - LINAC SCALPEL TREATMENT PLANNING SYSTEM

K962792 is an FDA 510(k) clearance for LINAC SCALPEL TREATMENT PLANNING SYSTEM, manufactured by Surgical Navigation Technologies, Inc.. The device is a Class 2 Radiology device with product code IYE cleared through the Traditional 510(k) pathway after a 118-day FDA review.

K962792 · Surgical Navigation Technologies, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1996
Decision
118d
Days
Class 2
Risk

K962792 is an FDA 510(k) clearance for the LINAC SCALPEL TREATMENT PLANNING SYSTEM. Classified as Accelerator, Linear, Medical (product code IYE), Class II - Special Controls.

Submitted by Surgical Navigation Technologies, Inc. (Broomfield, US). The FDA issued a Cleared decision on November 12, 1996 after a review of 118 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Surgical Navigation Technologies, Inc. devices

FDA 510(k) Submission Details - K962792

510(k) Number K962792 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 17, 1996
Decision Date November 12, 1996
Days to Decision 118 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d slower than avg
Panel avg: 107d · This submission: 118d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYE Device Classification - Class 2, Special Controls

Product Code IYE Accelerator, Linear, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYE Accelerator, Linear, Medical

All 583
Devices cleared under the same product code (IYE) and FDA review panel - the closest regulatory comparables to K962792.
THE NOMOS TALON POSITIONING AND IMMOBILIZATION SYSTEM
K963860 · Nomos Corp. · Dec 1996
PHILIPS SLI SERIES LINEAR ACCELERATOR
K963624 · Philips Medical Systems, Inc. · Dec 1996
PEACOCK SYSTEM
K963258 · Nomos Corp. · Nov 1996
THERAPLAN PLUS
K954679 · Theratronics, Inc. · Nov 1996
CASS SYSTEM (MODIFICATION)
K961484 · Medical Instrumentation & Diagnostics Corp.(Midco) · Nov 1996
BREAST TREATMENT AID M200
K962487 · S. and H. Engineering, Inc. · Sep 1996